Mitch Collett
Stock Analyst at Deutsche Bank
(1.22)
# 3,409
Out of 4,711 analysts
15
Total ratings
45.45%
Success rate
-7.82%
Average return
Main Sectors:
Stocks Rated by Mitch Collett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CCEP Coca-Cola Europacific Partners | Maintains: Buy | $78 → $90 | $75.17 | +19.73% | 5 | Sep 9, 2024 | |
| KPTI Karyopharm Therapeutics | Maintains: Outperform | $8 → $5 | $0.64 | +687.40% | 2 | Aug 7, 2024 | |
| BUD Anheuser-Busch InBev | Upgrades: Buy | n/a | $50.21 | - | 1 | Jun 22, 2023 | |
| DEO Diageo | Downgrades: Sell | n/a | $125.47 | - | 5 | Jun 29, 2022 | |
| UL Unilever | Downgrades: Hold | n/a | $57.16 | - | 2 | Sep 16, 2021 |
Coca-Cola Europacific Partners
Sep 9, 2024
Maintains: Buy
Price Target: $78 → $90
Current: $75.17
Upside: +19.73%
Karyopharm Therapeutics
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $5
Current: $0.64
Upside: +687.40%
Anheuser-Busch InBev
Jun 22, 2023
Upgrades: Buy
Price Target: n/a
Current: $50.21
Upside: -
Diageo
Jun 29, 2022
Downgrades: Sell
Price Target: n/a
Current: $125.47
Upside: -
Unilever
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $57.16
Upside: -